ArticleCureus2026
The High Burden of Dyslipidemia in Ibb, Yemen: A Retrospective Analysis From 2018 to 2026 of Gender and Age Associations in 14,691 Individuals.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDyslipidemia is a major modifiable risk factor for cardiovascular disease. Despite its global burden, data from Yemen remain scarce. This study aimed to determine the prevalence of lipid abnormalities and their associations with age, gender, and vitamin D deficiency among patients attending a specialized endocrinology and diabetes clinic in Ibb, Yemen.
methodsWe conducted a cross‑sectional study of 14,691 individuals in Ibb, Yemen, using electronic medical records from the Medical City Complex (July 2018-January 2026). Demographic and lipid parameters were extracted, with categories defined by international guidelines. Statistical analyses were performed using appropriate parametric and non‑parametric tests, with significance set at p < 0.05.
resultsA total of 14,691 patients were analyzed. Most had normal total cholesterol (85.2%), while borderline or high levels were more frequent in females. Triglyceride abnormalities were common, with nearly one‑quarter showing high values (>199 mg/dL), slightly more in males. Low high‑density lipoprotein cholesterol (HDL‑C) was highly prevalent (72.9%), while high HDL‑C was rare (0.9%). Low‑density lipoprotein cholesterol (LDL‑C) abnormalities were found in 8.6%, more frequently in females. Both gender and age were strongly associated with lipid variability (p < 0.001): females consistently exhibited higher total cholesterol, LDL‑C, and HDL‑C, whereas males had higher triglycerides. Middle‑aged adults carried the greatest burden of abnormal triglycerides and LDL‑C, while older adults were more prone to low HDL‑C. Overall, gender and age emerged as the strongest determinants of dyslipidemia.
conclusionLipid abnormalities are widespread in this Yemeni cohort, with low HDL‑C and elevated triglycerides being the most prominent. Gender and age were the strongest determinants of lipid variability, underscoring the need for sex‑ and age‑specific strategies in cardiovascular risk management. These findings align with international evidence and highlight the importance of tailored prevention policies in resource‑limited settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.